Skip to content

Improving The Breast Cancer Care Delivery Model for Sex and Gender Minority Survivors, Intended for SGM Study

Improving the Breast Cancer Care Delivery Model for Sex and Gender Minority Survivors (Intended for SGM)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06205394
Enrollment
28
Registered
2024-01-16
Start date
2022-08-24
Completion date
2023-10-15
Last updated
2024-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Carcinoma

Brief summary

This study evaluates Improving the Breast Cancer Care Delivery Model for Sex and Gender Minority (INTENDED for SGM) in identifying the patient, support person and provider barriers to quality care in SGM breast/chest cancer survivors.

Detailed description

PRIMARY OBJECTIVE: I. To determine the important ways the iCanDecide breast cancer decision aid needs revised for SGM people, and how best to integrate a culturally-relevant tool into clinical practice. OUTLINE: This is an observational study. AIM 1: Interview transcripts from SANGRIA study utilized to explore the values, preferences and key considerations for breast cancer treatment decision making in SGM individuals. AIM 2: Patients are assigned to 1 of 2 groups. GROUP 1: Cancer survivors participate in a focus group on study. GROUP 2: Breast cancer clinicians undergo a semi-structured interview on study.

Interventions

OTHERNon-Interventional Study

Non-interventional study

Sponsors

Ohio State University Comprehensive Cancer Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* SURVIVORS: * Self-identify as a member of the sex and gender minority community or partner with an individual of the same sex or gender * Must be a breast cancer survivor, in active treatment or completed active treatment in the last 10 years (not including hormone therapy) * Be over age 18 * English-speaking * Received care in the US BREAST ONCOLOGY CLINICIANS: Physicians, advanced practice providers, nurses, psychologists and social workers will be eligible if they: * Provide care and/or surgical decision support to individuals diagnosed with early stage breast cancer in the US * Are English-speaking

Design outcomes

Primary

MeasureTime frameDescription
Survivor participant feedback, opinions, and preferences for breast cancer careAt completion of study up to 2 yearsData is verbally reported and collected in focus groups
Clinician participant reports of experiences, opinions, and knowledge of caring for LGBTQ+ peopleAt completion of study up to 2 yearsData is verbally reported and collected in interviews

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026